Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)
Clinical trial NCT03268889 · UNKNOWN
Trial details
- NCT number
- NCT03268889
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2020-06-15
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.